Nevada Medicaid and GLP-1s
Nevada writes its pharmacy policy into a manual, and the manual is unusually blunt. Weight loss on its own doesn't get you a GLP-1. Two other routes exist, and both of them are gated by a specialist: a cardiologist or vascular specialist for Wegovy, a documented sleep study for Zepbound. Each one is also closed to anyone who has diabetes.
What changed, and what the document says
The general rule
Not coveredOne clause, sitting inside the approval criteria for the whole class.
“Medication is not being prescribed for weight loss in absence of T2DM indication;”
Nevada Medicaid, Division of Health Care Financing and Policy — August 3, 2026
Who signs for Wegovy
Conditions applyNot a requirement to try a specialist. A requirement to involve one before the claim will pay.
“Wegovy® must be prescribed by, or in consultation with, a cardiologist or vascular specialist; and”
Nevada Medicaid, Division of Health Care Financing and Policy — August 3, 2026
Diabetes disqualifies you here
Conditions applyThe exception exists for people who don't have diabetes. If you do, the manual sends you elsewhere.
“Recipient must not have type 1 or type 2 diabetes. Recipients with type 1 or type 2 diabetes must have appropriate diabetic care with an alternative therapy as this indication is specific to non-diabetic recipients; and”
Nevada Medicaid, Division of Health Care Financing and Policy — August 3, 2026
Zepbound's one indication
Conditions applySleep apnea, and the manual wants records rather than a diagnosis code.
“Medication is being prescribed for moderate to severe obstructive sleep apnea (OSA) in adults with obesity, with OSA defined by one of the following [submission of records required]:”
Nevada Medicaid, Division of Health Care Financing and Policy — August 3, 2026
How long an approval lasts
Conditions applySix months on both exception routes, against a full year on the ordinary diabetes pathway.
“Initial and recertification approval will be for six months.”
Nevada Medicaid, Division of Health Care Financing and Policy — August 3, 2026
What changed in August
ContextThe whole revision, in the transmittal's own summary. It is about refills, not about who qualifies.
“Updated refill quantity requirements for GLP-1s.”
Nevada Medicaid, Division of Health Care Financing and Policy — August 3, 2026
GLP-1s escape the 100-day rule
CoveredNevada makes maintenance drugs go out in three-month fills. Diabetes GLP-1s are carved out of that.
“Anticonvulsants, and thyroid preparations, and GLP-1s for diabetes are considered maintenance medications but are not required to be filled in a three-month (100-day) supply.”
Nevada Medicaid, Division of Health Care Financing and Policy — August 3, 2026
Read the page footer, not the cover
ContextThe version is dated August 3, 2026, and the pages carrying the Wegovy and Zepbound criteria are footed January 5, 2026. One document, several ages.
“These revisions were heard and approved through the Public Hearing process pursuant to Nevada Revised Statutes (NRS) 422.2369 on July 28, 2026, and became effective August 3, 2026.”
Nevada Medicaid, Division of Health Care Financing and Policy — August 3, 2026
Which of these companies serve Nevada?
Of the 159 companies we grade, 19 publish a list of the states they are licensed in. We checked 137 more and found no such list on any page we read; 3 we have not checked either way.
13 of those lists name Nevada: Gala Health, Care Bare Rx, Vita Bella, TelePeptide, Levity, Wisp, WePeptideRx, Ways2Well, TeleClinic, Tyde Wellness, Willow, The Virtual NP and VevaRx. That is a licensure claim each company makes about itself, not something we checked with a state board.
A published list is a starting point, not a guarantee. If availability decides your choice, ask before you pay and get the answer in writing.
Sources
Each document below was fetched and read on the date shown beside it, which is the date printed on the document — not always the date in its web address. All of them were read in September 2026, the same session as the rest of this page.
- Medicaid Services Manual Chapter 1200 — Prescribed Drugs — Nevada Medicaid, Division of Health Care Financing and Policy. the effective date stated in the transmittal letter dated July 28, 2026 — individual pages carry their own older footers, which the facts below name where it matters: August 3, 2026.
Nothing on this page is medical advice, and nobody here is a clinician. Coverage rules change; check the linked document before you rely on it.
If you're paying cash instead
None of the above changes what a telehealth seller charges you. None of the 3 rows below carries both a medication price and a monthly fee we could capture, so no figure here is a sum. Each cell says what its number covers and what we could not confirm, and every number was read on the seller's own page.
Henry Meds, QuickMD and Zealthy pay us nothing — none of the 3 below does. The buttons run through our own redirect so we can count the click, and counting is all they do.
| Grade | Provider | What a month actually costs | The one thing that matters here | Go to the provider |
|---|---|---|---|---|
| BMinor gap | Henry Meds | $179a month, medication onlycompounded liraglutideMedication only. We captured no separate monthly charge on the pages we read, which is what we found rather than proof that nothing else is billed.Daily compounded liraglutide injections, up to 90 mg every 60 days, injection kit included. This is the cheapest injectable Henry sells and the number its product-page FAQ quotes as the starting price.The lowest of the 3 medication prices we captured here | Publishes a complete month-to-month price for every plan with the dose ceiling attached, which is rare. The catch is that the $179 you meet while shopping is the liraglutide floor and injectable semaglutide runs $297. | See its prices at Henry Meds (opens in a new tab)Pays us nothing |
| BMinor gap | QuickMD | No month-to-month medication price we could capture, so there is no monthly total to show.Charged per visit rather than every month, so it is not in the figure above: $99 for weight loss visit.The review says what else we found. | A $99 visit with no membership, and it says plainly that drug costs vary by pharmacy — which is the right tool if what you actually need is somebody to file the prior authorization. | See its prices at QuickMD (opens in a new tab)Pays us nothing |
| CCaveat | Zealthy | $297a month, medication onlycompounded semaglutideMedication only. We captured no separate monthly charge on the pages we read, which is what we found rather than proof that nothing else is billed.Advertised at $151The lowest of the 2 medication prices we captured here | Advertises semaglutide as low as $151 and tirzepatide at $216, while its own FAQ prices the bundle that keeps a prescription alive at $297 and $449. | See its prices at Zealthy (opens in a new tab)Pays us nothing |
Our grading method and how we verify a price explain what those letters mean and where these figures came from.